Trial Profile

Phase II Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 08 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mogamulizumab (Primary)
Indications Cutaneous T-cell lymphoma; Peripheral T-cell lymphoma
Focus Therapeutic Use
Sponsors Kyowa Hakko Kirin; Kyowa Kirin

Most Recent Events

16 Dec 2019 Results assessing population pharmacikinetic modeling by using data from six studies including this study published in the Journal of Clinical Pharmacology.
22 Jul 2013 Primary endpoint 'Objective-clinical-response' has been met according to a company media release.
01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com